Literature DB >> 11091548

Ca&sup2+;-Dependent Neutral Protease (Calpain) Activity in Breast Cancer Tissue and Estrogen Receptor Status.

.   

Abstract

Cancer invasion and metastasis require action of tumor-associated proteases, which degrade the extracellular matrix. It has been reported that calpain, a calcium-activated neutral protease and a thiol protease regulated by Ca&sup2+;, proteolyzes estrogen recepor (ER) and that calpain may play an important role in the regulation of ER function. In the present study, the activities of calpain were measured in human normal breast tissues and breast cancer tissues stratified by estrogen receptor levels. There were no correlations between calpain activity and tumor size or lymph node involvement. Activities of calpain were significantly higher in breast cancer tissues compared with those of normal breast tissues, and were higher in the ER-positive tumors than in ER-negative ones. These results indicate that calpain is related to mammary malignant transformation and is involved in the regulation of the ER function in breast cancer tissues.

Entities:  

Year:  1996        PMID: 11091548     DOI: 10.1007/BF02966957

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  16 in total

1.  Membrane binding and autolytic activation of calpain-I in human platelets.

Authors:  H Ariyoshi; E Shiba; M Sakon; J Kambayashi; T Kawasaki; J Kang; S Kawashima; T Mori
Journal:  Biochem Int       Date:  1992-07

2.  Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancer.

Authors:  M J Duffy; D Reilly; C O'Sullivan; N O'Higgins; J J Fennelly; P Andreasen
Journal:  Cancer Res       Date:  1990-11-01       Impact factor: 12.701

3.  Multiple forms of phosphoinositide-specific phospholipase C of different relative molecular masses in animal tissues. Evidence for modification of the platelet enzyme by Ca2+-dependent proteinase.

Authors:  M G Low; R C Carroll; W B Weglicki
Journal:  Biochem J       Date:  1984-08-01       Impact factor: 3.857

4.  Suppression by cathepsin L inhibitors of the invasion of amnion membranes by murine cancer cells.

Authors:  S Yagel; A H Warner; H N Nellans; P K Lala; C Waghorne; D T Denhardt
Journal:  Cancer Res       Date:  1989-07-01       Impact factor: 12.701

5.  Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators.

Authors:  H Cho; B S Katzenellenbogen
Journal:  Mol Endocrinol       Date:  1993-03

6.  Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary report.

Authors:  M J Duffy; P O'Grady; D Devaney; L O'Siorain; J J Fennelly; H J Lijnen
Journal:  Cancer       Date:  1988-08-01       Impact factor: 6.860

7.  Purification and characterization of Ca2+-activated neutral protease inhibitor from human platelets.

Authors:  E Shiba; T Tsujinaka; J Kambayashi; G Kosaki
Journal:  Thromb Res       Date:  1983-10-15       Impact factor: 3.944

8.  International comparisons concerning breast cancer and steroid receptors.

Authors:  K Matsumoto; G Sakamoto; Y Nomura
Journal:  Anticancer Res       Date:  1986 Jul-Aug       Impact factor: 2.480

9.  Tissue-type plasminogen activator, a new prognostic marker in breast cancer.

Authors:  M J Duffy; P O'Grady; D Devaney; L O'Siorain; J J Fennelly; H R Lijnen
Journal:  Cancer Res       Date:  1988-03-01       Impact factor: 12.701

Review 10.  Cathepsin D: a protease involved in breast cancer metastasis.

Authors:  H Rochefort; F Capony; M Garcia
Journal:  Cancer Metastasis Rev       Date:  1990-12       Impact factor: 9.264

View more
  11 in total

1.  Calpain 2 is required for glioblastoma cell invasion: regulation of matrix metalloproteinase 2.

Authors:  Hyo Sang Jang; Sangeet Lal; Jeffrey A Greenwood
Journal:  Neurochem Res       Date:  2010-08-21       Impact factor: 3.996

2.  Genome-wide association study identifies a possible susceptibility locus for endometrial cancer.

Authors:  Jirong Long; Wei Zheng; Yong-Bing Xiang; Felicity Lose; Deborah Thompson; Ian Tomlinson; Herbert Yu; Nicolas Wentzensen; Diether Lambrechts; Thilo Dörk; Natalia Dubrowinskaja; Marc T Goodman; Helga B Salvesen; Peter A Fasching; Rodney J Scott; Ryan Delahanty; Ying Zheng; Tracy O'Mara; Catherine S Healey; Shirley Hodgson; Harvey Risch; Hannah P Yang; Frederic Amant; Nurzhan Turmanov; Anita Schwake; Galina Lurie; Jone Trovik; Matthias W Beckmann; Katie Ashton; Bu-Tian Ji; Ping-Ping Bao; Kimberly Howarth; Lingeng Lu; Jolanta Lissowska; Lieve Coenegrachts; Dilyara Kaidarova; Matthias Dürst; Pamela J Thompson; Camilla Krakstad; Arif B Ekici; Geoffrey Otton; Jiajun Shi; Ben Zhang; Maggie Gorman; Louise Brinton; An Coosemans; Rayna K Matsuno; Mari K Halle; Alexander Hein; Anthony Proietto; Hui Cai; Wei Lu; Alison Dunning; Douglas Easton; Yu-Tang Gao; Qiuyin Cai; Amanda B Spurdle; Xiao-Ou Shu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-03-16       Impact factor: 4.254

3.  Global analysis of protein folding thermodynamics for disease state characterization.

Authors:  Jagat Adhikari; Graham M West; Michael C Fitzgerald
Journal:  J Proteome Res       Date:  2015-04-09       Impact factor: 4.466

4.  Fibronectin induces epithelial-mesenchymal transition in human breast cancer MCF-7 cells via activation of calpain.

Authors:  Cheng-Lin Li; Dan Yang; Xin Cao; Fan Wang; Duan-Yang Hong; Jing Wang; Xiang-Chun Shen; Yan Chen
Journal:  Oncol Lett       Date:  2017-03-23       Impact factor: 2.967

Review 5.  Calpains as potential anti-cancer targets.

Authors:  Ludovic Leloup; Alan Wells
Journal:  Expert Opin Ther Targets       Date:  2011-01-19       Impact factor: 6.902

6.  Calpain activity is generally elevated during transformation but has oncogene-specific biological functions.

Authors:  N O Carragher; B D Fonseca; M C Frame
Journal:  Neoplasia       Date:  2004 Jan-Feb       Impact factor: 5.715

7.  Low calpain-9 is associated with adverse disease-specific survival following endocrine therapy in breast cancer.

Authors:  Jillian Davis; Stewart G Martin; Poulam M Patel; Andrew R Green; Emad A Rakha; Ian O Ellis; Sarah J Storr
Journal:  BMC Cancer       Date:  2014-12-23       Impact factor: 4.430

8.  Silencing CAPN2 Expression Inhibited Castration-Resistant Prostate Cancer Cells Proliferation and Invasion via AKT/mTOR Signal Pathway.

Authors:  Pu Li; Chenkui Miao; Chao Liang; Pengfei Shao; Zengjun Wang; Jie Li
Journal:  Biomed Res Int       Date:  2017-02-09       Impact factor: 3.411

9.  The calpain/calpastatin system has opposing roles in growth and metastatic dissemination of melanoma.

Authors:  Quentin Raimbourg; Joëlle Perez; Sophie Vandermeersch; Aurélie Prignon; Guillaume Hanouna; Jean-Philippe Haymann; Laurent Baud; Emmanuel Letavernier
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

10.  The growth and tumor suppressors NORE1A and RASSF1A are targets for calpain-mediated proteolysis.

Authors:  Sergey Kuznetsov; Andrei V Khokhlatchev
Journal:  PLoS One       Date:  2008-12-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.